Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Abstracts In Press
    • Archives
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

  • Log out

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
  • Log out
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Abstracts In Press
    • Archives
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleOriginal Research

Impact of Pharmacist Previsit Input to Providers on Chronic Opioid Prescribing Safety

Nicholas Cox, Casey R. Tak, Susan E. Cochella, Eric Leishman and Karen Gunning
The Journal of the American Board of Family Medicine January 2018, 31 (1) 105-112; DOI: https://doi.org/10.3122/jabfm.2018.01.170210
Nicholas Cox
From the Department of Pharmacy Services (NC, KG) and Department of Family and Preventive Medicine (SEC), University of Utah Health, Salt Lake City; the Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City (NC, CRT, EL, KG); and the Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City (SEC, KG).
PharmD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Casey R. Tak
From the Department of Pharmacy Services (NC, KG) and Department of Family and Preventive Medicine (SEC), University of Utah Health, Salt Lake City; the Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City (NC, CRT, EL, KG); and the Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City (SEC, KG).
BA, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan E. Cochella
From the Department of Pharmacy Services (NC, KG) and Department of Family and Preventive Medicine (SEC), University of Utah Health, Salt Lake City; the Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City (NC, CRT, EL, KG); and the Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City (SEC, KG).
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Leishman
From the Department of Pharmacy Services (NC, KG) and Department of Family and Preventive Medicine (SEC), University of Utah Health, Salt Lake City; the Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City (NC, CRT, EL, KG); and the Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City (SEC, KG).
PharmD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen Gunning
From the Department of Pharmacy Services (NC, KG) and Department of Family and Preventive Medicine (SEC), University of Utah Health, Salt Lake City; the Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City (NC, CRT, EL, KG); and the Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City (SEC, KG).
PharmD, BCPS, BCACP, FCCP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 31 no. 1 105-112
DOI 
https://doi.org/10.3122/jabfm.2018.01.170210
PubMed 
29330245

Published By 
The Journal of the American Board of Family Medicine
Print ISSN 
1557-2625
Online ISSN 
1558-7118
History 
  • Received for publication May 24, 2017
  • Revision received August 28, 2017
  • Accepted for publication September 1, 2017
  • Published online January 12, 2018.

Copyright & Usage 
© Copyright 2018 by the American Board of Family Medicine.

Author Information

  1. Nicholas Cox, PharmD,
  2. Casey R. Tak, BA, MPH,
  3. Susan E. Cochella, MD, MPH,
  4. Eric Leishman, PharmD and
  5. Karen Gunning, PharmD, BCPS, BCACP, FCCP
  1. From the Department of Pharmacy Services (NC, KG) and Department of Family and Preventive Medicine (SEC), University of Utah Health, Salt Lake City; the Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City (NC, CRT, EL, KG); and the Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City (SEC, KG).
  1. Corresponding author: Nicholas Cox, PharmD, Department of Pharmacy Services, University of Utah Health, 50 N. Medical Drive, A-090M, Salt Lake City, UT 84132 (E-mail: nicholas.cox{at}pharm.utah.edu).
View Full Text

Cited By...

  • 32 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family     Medicine: 31 (1)
The Journal of the American Board of Family Medicine
Vol. 31, Issue 1
January-February 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Impact of Pharmacist Previsit Input to Providers on Chronic Opioid Prescribing Safety
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
16 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Impact of Pharmacist Previsit Input to Providers on Chronic Opioid Prescribing Safety
Nicholas Cox, Casey R. Tak, Susan E. Cochella, Eric Leishman, Karen Gunning
The Journal of the American Board of Family Medicine Jan 2018, 31 (1) 105-112; DOI: 10.3122/jabfm.2018.01.170210

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Impact of Pharmacist Previsit Input to Providers on Chronic Opioid Prescribing Safety
Nicholas Cox, Casey R. Tak, Susan E. Cochella, Eric Leishman, Karen Gunning
The Journal of the American Board of Family Medicine Jan 2018, 31 (1) 105-112; DOI: 10.3122/jabfm.2018.01.170210
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Conclusions
    • Appendix
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Designing a primary care pharmacist-led review for people treated with opioids for persistent pain: a multi-method qualitative study
  • Adoption of opioid-prescribing guidelines in primary care: a realist synthesis of contextual factors
  • Strategies supporting sustainable prescribing safety improvement interventions in English primary care: a qualitative study
  • Technology-Enabled and Artificial Intelligence Support for Pre-Visit Planning in Ambulatory Care: Findings From an Environmental Scan
  • Impact of Physician-Pharmacist Collaboration on Diabetes Outcomes and Health Care Use
  • A New Quality Improvement Toolkit to Improve Opioid Prescribing in Primary Care
  • Interventions Must Be Realistic to Be Useful and Completed in Family Medicine
  • Google Scholar

More in this TOC Section

  • Evaluating Pragmatism of Lung Cancer Screening Randomized Trials with the PRECIS-2 Tool
  • Regional Variation in Scope of Practice by Family Physicians
  • Successful Implementation of Integrated Behavioral Health
Show more Original Research

Similar Articles

Keywords

  • Benzodiazepines
  • Chronic Pain
  • Drug Monitoring
  • Naloxone
  • Opioid Analgesics
  • Pain Management
  • Pharmacists
  • Pilot Study
  • Prescriptions
  • Primary Health Care
  • Quality Improvement
  • Referral and Consultation

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire